A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.

OBJECTIVE The goal of this study was to investigate the use of proton magnetic resonance spectroscopic imaging as a prognostic indicator in gamma knife radiosurgery of recurrent gliomas. METHODS Thirty-six patients with recurrent gliomas were studied with proton magnetic resonance spectroscopic imaging at the time of radiosurgery, and with conventional magnetic resonance imaging examinations at regular time intervals until the initiation of a new treatment strategy. Patients were categorized on the basis of their initial spectroscopic results, and their performance was assessed in terms of change in contrast-enhancing volume, time to further treatment, and survival. RESULTS The trends in the overall population were toward more extensive increase in the percent contrast-enhancing volume, a decreased time to further treatment, and a reduced survival time for patients with more extensive initial metabolic abnormalities. Statistical analysis of the subpopulation of patients with glioblastoma multiforme found a significant increase in relative contrast-enhancing volume (P < 0.01, Wilcoxon signed-rank test), a decrease in time to further treatment (P < 0.01, log-rank test), and a reduction in survival time (P < 0.01, log-rank test) for patients with regions containing tumor-suggestive spectra outside the gamma knife target, compared with patients exhibiting spectral abnormalities restricted to the gamma knife target. Further studies are needed to establish statistical significance for patients with lower-grade lesions and to confirm the results observed in this study. CONCLUSION The pretreatment spectroscopic results provided information that was predictive of outcome for this patient pool, both in local control (change in contrast-enhancing volume) and global outcome (time to further treatment and survival). This modality may have an important role in improving the selection, planning, and treatment process for glioma patients.

[1]  Susan M. Chang,et al.  Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: Presentation of a detailed case study , 1997, Journal of magnetic resonance imaging : JMRI.

[2]  D. Kondziolka,et al.  Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. , 1997, Neurosurgery.

[3]  P. Wen,et al.  Radiosurgery as part of the initial management of patients with malignant gliomas. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Sheline.  Radiation therapy of brain tumors , 1977, Cancer.

[5]  D. Kondziolka,et al.  Radiobiologic models for radiosurgery. , 1992, Neurosurgery clinics of North America.

[6]  M. Mehta,et al.  Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. , 1994, International journal of radiation oncology, biology, physics.

[7]  J. Pauly,et al.  Improved solvent suppression and increased spatial excitation bandwidths for three‐dimensional press CSI using phase‐compensating spectral/spatial spin‐echo pulses , 1997, Journal of magnetic resonance imaging : JMRI.

[8]  D. Kondziolka,et al.  Gamma knife for glioma: selection factors and survival. , 1996, International journal of radiation oncology, biology, physics.

[9]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[10]  D B Vigneron,et al.  Registration of images from sequential MR studies of the brain , 1994, Journal of magnetic resonance imaging : JMRI.

[11]  R F Young,et al.  The role of the gamma knife in the treatment of malignant primary and metastatic brain tumors , 1998, CA: a cancer journal for clinicians.

[12]  D. Shrieve,et al.  Advances in radiation therapy for brain tumors. , 1995, Neurologic clinics.

[13]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.